Cheung Ka Wai, Faye obtained my PhD from The University of Hong Kong in 2010. Afterwards, he has been a postdoctoral fellow at the AIDS Institute, The University of Hong Kong and at Emerging Infectious Diseases Programme, Duke-NUS Medical School inSingapore. He has been fascinated in T cell immunology since his PhD. During and has gained experience in various aspects of T cell research, with major focus on drug development for modulating T cell responses and the role of T cells in infectious diseases, e.g. HIV-1/AIDS and Dengue. He has published in the Journal of Infectious Diseases, Journal of Virology, PLOSOne, Journal of Ethnopharmacology, etc.. Besides, he was the Principal investigator and co-investigator for some funded research projects.

‍

In SMART-CAMP, he is working in Associate Prof. Michael Birnbaum’s team to identify the label-free critical quality attributes (CQAs) for monitoring the chimeric antigen receptor-T cells (CAR-T) manufacturing process. My current research is mainly focusing on investigating the use of soluble factors in the cell culture, e.g. metabolites for evaluating the healthiness of T cell proliferation. Asan immunologist in SMART-CAMP, I also work with colleagues from engineering background to investigate the potential application of technologies e.g. Deterministic LateralDisplacement (DLD) microfluidic technology and Magnetic Resonance Relaxometry (MMR) for improving CAR-T manufacture process.

‍